Exhaled nitric oxide (FeNO) in relation to exacerbation of childhood asthma Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma Year: 2009
Stability of exhaled nitric oxide (FE NO) in patients with severe, steroid-dependent asthma Source: Annual Congress 2008 - Clinical utility of exhaled nitric oxide measurement Year: 2008
Relationship between exhaled nitric oxide (eNO) and sputum eosinophils in severe asthma Source: Eur Respir J 2004; 24: Suppl. 48, 596s Year: 2004
Relationship between exhaled nitric oxide (eNO), atopy and asthma in children. ISAAC-clermont-ferrand Source: Eur Respir J 2001; 18: Suppl. 33, 38s Year: 2001
Exhaled nitric oxide (FENO) in patients with rhinitis and asthma-like symptoms Source: Eur Respir J 2005; 26: Suppl. 49, 280s Year: 2005
Is exhaled nitric oxide (eNO) an indipendent outcome measure in chronic stable asthma? Source: Eur Respir J 2002; 20: Suppl. 38, 196s Year: 2002
Exhaled nitric oxide (eNO) levels in asthmatic children: relation to atopy and airway responsiveness (AHR) Source: Eur Respir J 2004; 24: Suppl. 48, 271s Year: 2004
Screening with exhaled nitric oxide (ENO) may identify cases with on-going bronchial inflammation but not asthma symptoms Source: Eur Respir J 2001; 18: Suppl. 33, 38s Year: 2001
High levels of fractional exhaled nitric oxide (FeNO) in severe oral steroid-dependent asthma are associated with eosinophilia and atopy Source: Annual Congress 2009 - Airway inflammation and asthma control Year: 2009
Rint, exhaled nitric oxide and the prediction of asthma and respiratory symptoms in children Source: Eur Respir J 2005; 26: Suppl. 49, 479s Year: 2005
The clinical utility of exhaled nitric oxide (eNO) in asthma, the first 1,000 patients Source: Eur Respir J 2004; 24: Suppl. 48, 304s Year: 2004
Increased serum levels of IL-8 and TNFα in severe asthma compared to mild asthma: relationship with airway calibre and exhaled nitric oxide (FeNO) Source: Eur Respir J 2004; 24: Suppl. 48, 351s Year: 2004
Exhaled nitric oxide predicts control in patients with difficult-to-treat asthma Source: Eur Respir J 2010; 35: 1221-1227 Year: 2010
The experience of monitoring the exhaled nitric oxide (FeNO) during the anti-IgE-therapy (omalizumab) in children with uncontrolled severe asthma Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015
Sputum inflammatory biomarkers and exhaled nitric oxide (FENO ) in varying severity asthmatics Source: Eur Respir J 2006; 28: Suppl. 50, 445s Year: 2006
Relationship between baseline fraction of exhaled nitric oxide (FeNO) and response to anti-IL-5/5R therapies in severe eosinophilic asthma (SEA) Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma Year: 2020
Exhaled nitric oxide and lower airway involvement in persistent rhinitis Source: Annual Congress 2006 - Monitoring airway inflammation – exhaled markers vs induced sputum Year: 2006
Comparisons for concentration in exhaled nitric oxide between patients with bronchial asthma and COPD Source: Annual Congress 2007 - Pathophysiology and assessment of COPD Year: 2007
Exhaled nitric oxide, nitrite/nitrate levels, allergy, rhinitis and asthma in the EGEA study Source: Eur Respir J 2014; 44: 351-360 Year: 2014
Exhaled nitric oxide predicts lung function decline in difficult-to-treat asthma Source: Eur Respir J 2008; 32: 344-349 Year: 2008